A new study indicates that the drug suvorexant could reduce proteins associated with Alzheimer's by improving sleep quality.

A UF study finds that two common diabetes drugs may help protect against Alzheimer’s disease in older adults with Type 2 ...

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering ...

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Now, an analysis of Alzheimer’s diagnoses in people who were prescribed semaglutide or other medications for type 2 diabetes examines whether cases of Alzheimer’s disease emerged at different ...